Pharmidex will be attending “The 17th Annual BIO CEO & Investor Conference”
Feb 09, 2015

The BIO CConference is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies.

Pharmidex will be attending “The 17th Annual BIO CEO & Investor Conference”

The BIO CEO & Investor Conference is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies.


Those attending the conference will have the opportunity to explore a broad variety of industry related investment opportunities. Additionally delegates would have a chance to network with institutional investors, industry analysts & senior biotechnology executives. 


Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities. BIO One-on-One Partnering provides an opportunity to arrange meetings between investors; companies; and industry BD, licensing and therapeutic franchise heads.


The event will be taking place on the 9-10 February 2015, New York City, NY, USA.


For more information please follow the link: https://www.bio.org/events/conferences/bio-ceo-investor-conference

24 Apr, 2024
Pharmidex , in collaboration with colleagues at the University of Brighton, is pleased to announce publication of our latest article
13 Mar, 2024
Uncover valuable insights from a range of sources including plasma, bronchoalveolar lavage fluid, urine, and tissue supernatant with our comprehensive matrix evaluation services.
By Ash Alavijeh 26 Feb, 2024
As an accredited GLP/GCP laboratory, Pharmidex provides comprehensive bioanalytical solutions tailored to meet your specific drug development needs.
More Posts
Share by: